DSIP 5MG

Des-Gly[1]-Serotonin-Lysine Peptide (DSIP), presented in a 5mg research-grade formulation, is a synthetic peptide derived from the natural hormone des-arg[1]-vasopressin. It is widely utilized in academic and industrial research for its defined biochemical properties and potential implications in neurological, pharmacological, and physiological studies. This product is intended solely for use in research environments and does not contain any therapeutic claims or applications.

Research Context

Des-Gly[1]-Serotonin-Lysine Peptide (DSIP) is a synthetic modification of the naturally occurring peptide des-arg[1]-vasopressin, which exhibits vasopressin-like activity. DSIP is characterized by its absence of the arginine-glycine amide terminal, altering its pharmacological properties compared to native vasopressin. Originally discovered for its role in modulating sleep-wake cycles and circadian rhythms, DSIP has been extensively studied in rodent models for its potential effects on neuronal function, stress responses, and sleep regulation. Its structural simplicity and defined molecular profile make it a valuable tool for biochemical, pharmacological, and cellular research.

Research Overview

DSIP has been investigated primarily in preclinical studies involving rodents due to its distinct pharmacological profile compared to vasopressin. Early research highlighted its ability to suppress prolactin secretion in a manner distinct from oxytocin or vasopressin, suggesting a unique receptor-mediated pathway. Beyond endocrine effects, DSIP has been explored for its modulatory role in sleep architecture, particularly in the regulation of non-rapid eye movement (NREM) sleep. Additionally, its influence on stress physiology, including corticosterone levels, has been documented, making it a relevant probe for behavioral neuroscience research.

Key Research Focus Areas

• Neuroendocrine and Hormonal Regulation: DSIP has been studied for its effects on the hypothalamic-pituitary axis, particularly in modulating prolactin secretion and its interactions with other neuropeptides such as oxytocin and vasopressin.
• Circadian and Sleep Physiology: Research has examined DSIP’s role in modulating sleep-wake cycles, including its potential to enhance NREM sleep in rodent models.
• Stress and Anxiety Responses: Preclinical studies have investigated DSIP’s impact on stress-induced behaviors, including corticosterone levels and anxiety-related behaviors in animal models.
• Pharmacological Profiles and Receptor Binding: DSIP’s binding affinity and functional activity at vasopressin receptors have been characterized, distinguishing it from other vasotropic peptides.
• Biochemical and Cellular Studies: The peptide’s effects on cellular signaling pathways, protein interactions, and its use as a tool to dissect receptor-specific functions in neuronal cultures have been explored.

Safety and Compliance Note

The use of DSIP 5MG is intended exclusively for research purposes under the supervision of qualified professionals in accredited academic or industrial research settings. This product is not intended for human or animal consumption, therapeutic use, or diagnostic applications. Users must adhere to strict protocols for handling, storage, and disposal of research chemicals to ensure compliance with local regulations and safety standards.

For research use only. Not for human or animal consumption.